氯氮平对长期住院精神分裂症患者糖代谢的影响

杨兆正; 刘鹏; 陈海燕; 李金

doi:10.3969/j.issn.1672-2353.2011.11.017

氯氮平对长期住院精神分裂症患者糖代谢的影响

江苏省扬州五台山医院,精神科,江苏,扬州,225003

详细信息

中图分类号: R749.3
计量
- 文章访问数: 150
- HTML全文浏览量: 29
- PDF下载量: 7
出版历程
- 发布日期: 2011-09-29

Effects of Clozapine on glucose metabolism in chronic schizophrenic inpatients

摘要

摘要: 目的调查氯氮平对长期住院的精神分裂症患者糖代谢的影响.方法根据空腹静脉和餐后2 h静脉血糖水平,对服用氯氮平的长期住院男性精神分裂症患者进行糖尿病及与糖尿病相关状态的诊断.结果 67例患者中20例患者有糖尿病(29.8%),16例有糖耐量减低(IGT)(23.9%),6例有空腹血糖损害(IFG)(9%),25例为血糖代谢正常者(37.3%).根据氯氮平剂量、体质指数和服药时间的不同将患者各分成3组,3组间的糖代谢异常发生率差异无统计学意义.正常组、IFG组、IGT组以及糖尿病组患者在胆固醇水平、体质指数、氯氮平剂量、三酯甘油水平以及服药时间之间差异无统计学意义.在IFG组,体质指数与患者每天氯氮平服用剂量之间呈显著性正相关(r=0.889,P=0.019),而在IGT组,各临床资料之间无明显相关性.结论长期服用氯氮平对精神分裂症患者糖代谢有明显影响.
- 精神分裂症 /
- 氯氮平 /
- 空腹血糖损害 /
- 糖耐量减低 /
- 糖尿病

HTML全文

参考文献(18)

Lean M E, Pajonk F G. Patients on atypical antipsychotic drugs:another high-risk group for type 2 diabetes [J]. Diabetes Care, 2003(5):1597.doi: 10.2337/diacare.26.5.1597.

陈灏珠. 实用内科学 [M]. 北京:人民卫生出版社, 2002.952.

Kane J, Honigfeld G, Singer J. Clozapine for the treatment-resistant schizophrenic.A double blind comparison with chlorpromazine [J]. Archives of General Psychiatry, 1988(9):789.doi: 10.1001/archpsyc.1988.01800330013001.

Gentile S. Long-term treatment with atypical antipsychotics and the risk of weight gain [J]. Drug Safety, 2006(4):303.doi: 10.2165/00002018-200629040-00002.

Henderson D, Louie P, Koul P. Modafinil-associated weight loss in a clozapine-treated schizoaffective disorder patient [J]. Annals of Clinical Psychiatry, 2005(2):95.doi: 10.1080/10401230590932407.

李成, 张晓斌, 周朝昀. 长期服用氯氮平对精神分裂症患者糖代谢的影响 [J]. 中华医学研究杂志, 2004, (11):999.

Henderson DC, Cagliero E, Gray. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities:a five-year naturalistic study [J]. American Journal of Psychiatry, 2000(6):975.doi: 10.1176/appi.ajp.157.6.975.

Goethe J, Szarek B, Caley C. Signs and symptoms associated with the metabolic syndrome in psychiatric inpatients receiving antipsychotics.A retrospective chart review [J]. Journal of Clinical Psychiatry(S0160-6689), 2007(1):22.doi: 10.4088/JCP.v68n0103.

奚巍. 氯氮平治疗与糖耐量异常的相关性初探 [J]. 四川精神卫生, 2000(3):169.

刘燕, 朱玉华, 卢卫红. 精神病人伴发糖尿病的资料分析 [J]. 上海精神医学, 2001(1):29.doi: 10.3969/j.issn.1002-0829.2001.01.010.

郑一瑾, 王高华, 程自立. 氯氮平和利培酮对首发精神分裂症患者糖代谢影响的研究 [J]. 中华精神科杂志, 2003(4):207.doi: 10.3760/j:issn:1006-7884.2003.04.005.

Melkersson K I, Hulting A L. Insulin and leptin levels in patients with schizophrenia or related psychoses:a comparison between different antipsychotic agents [J]. Psychopharmacology(Berlin), 2001(2):205.

Allison D B, Mentore J L, Heo M. Antipsychotic-induced weight gain:a comprehensive research synthesis [J]. American Journal of Psychiatry, 1999, (11):1686.

Brunero S, Lamont S, Fairbrother G. Prevalence and Predictors of Metabolic Syndrome Among Patients Attending an Outpatient Clozapine Clinic in Australia [J]. Archives of Psychiatric Nursing, 2009(3):261.

王从杰, 张志珺, 孙静. 氯氮平和经典抗精神病药的长期治疗对患者体重、糖代谢及血脂的影响 [J]. 中国神经精神疾病杂志, 2008(2):65.doi: 10.3969/j.issn.1002-0152.2008.02.001.

周媛, 王高华, 王惠玲. 氯氮平对离体大鼠胰岛分泌的影响 [J]. 临床精神医学杂志, 2004(3):134.doi: 10.3969/j.issn.1005-3220.2004.03.003.

Procyshyn R, Wasan K, Thornton A. Changes in serum lipids, independent of weight, are associated with changes in symptoms during long term clozapine treatment [J]. Journal of Psychiatry and Neuroscience, 2007(5):331.

Koller E, Schneider B, Bennett K. Clozapine-associated diabetes [J].

施引文献

资源附件(0)

计量

文章访问数: 150
HTML全文浏览量: 29
PDF下载量: 7
被引次数: 0

氯氮平对长期住院精神分裂症患者糖代谢的影响

计量

出版历程

Effects of Clozapine on glucose metabolism in chronic schizophrenic inpatients

计量

出版历程

目录